Why Whole Foods Is Hot
Health Care: Health Services
Antares Pharma Inc. (AIS: NASDAQ)
$5.10 -0.10 | -1.92%
07/19/12 - 04:00 PM ET
3.20M / 1.08M
Vol / Avg. Vol:5.33 / 5.20
Open / Prev. Close:4.78 - 5.33
Today's Range:1.51 - 5.58
52 Wk Range:50.00%
Performance YTD:TheStreet Rating:
Portfolios with AIS
- Portfolio NameUser Type
- Contributor5 Stocks Under-$10 Setting ...
- UserSMITTY
- Contributor8 Health Care Stocks With R...
- ContributorBreakout Stocks Of The Week...
- UserCurrent
- Userparvardigar
- Userhpats Portfolio 1
- Contributor11 Penny Stocks to Sell Now
- Userphospho
- UserTraderO4000 Portfolio 1
Latest AIS Headlines from TheStreet
- Antares Reaches New 52-Week High (AIS) 06.26.12 | 11:06 am
- Antares Stock Hits New 52-Week High (AIS) 06.18.12 | 10:06 am
- Antares Stock Hits New 52-Week High (AIS) 03.20.12 | 11:03 am
- Antares Pharma Inc. Stock Upgraded (AIS) 03.14.12 | 05:03 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Antares Stock Gaps Down On Today's Open (AIS) 12.15.11 | 09:12 am
- BioSante Pharma Readying Release of 'Female Viagra' Study Results 12.14.11 | 12:12 pm
- 5 Stocks Under $10 With Big Upside Potential 11.18.11 | 06:11 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- 4 Stocks Setting Up to Break Out 06.10.11 | 03:06 pm
Press Releases for AIS
- Antares Pharma Announces Move To The NASDAQ Stock Market - Business Wire 06.06.12 | 07:06 am
- Antares Pharma To Present At The Jefferies Global Healthcare Conference - Business Wire 05.31.12 | 07:05 am
- Antares Pharma Reports First Quarter 2012 Financial And Operating Results - Business Wire 05.08.12 | 07:05 am
- Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva And Pfizer - Business Wire 04.26.12 | 09:04 am
- Antares Pharma To Present At The 11th Annual Needham Healthcare Conference - Business Wire 03.28.12 | 07:03 am
- Antares Pharma Reports Fourth Quarter And Full Year 2011 Financial And Operating Results - Business Wire 03.12.12 | 07:03 am
- Antares Pharma To Host Fourth Quarter And Full Year 2011 Earnings Call - Business Wire 03.05.12 | 07:03 am
- Antares Pharma To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 07:02 am
- Antares Pharma Appoints John J. Howarth Vice President Of Corporate Affairs - Business Wire 02.27.12 | 09:02 am
- Antares Pharma Enters Licensing Agreement With Daewoong Pharmaceuticals Co. Ltd. For Oxybutynin Gel 3% In South Korea - Business Wire 01.17.12 | 08:01 am
Partner Headlines for AIS
- Look For These 5 Biotech Stocks Heading North - Seeking Alpha 06.07.12 | 09:06 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 05.14.12 | 09:05 am
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell - Seeking Alpha 02.22.12 | 09:02 am
- SIGA Could Be Ready For A Large Short-Term Pop - Seeking Alpha 01.15.12 | 09:01 am
- Antares Pharma's New Blockbuster Drug Has Potential To Generate Long-Term Revenue - Seeking Alpha 12.28.11 | 06:12 am
- Watson-Amgen to Develop Biosimilars - Analyst Blog - Zacks 12.20.11 | 10:12 am
